HSDT
Helius Medical Technologies Inc Class A
NASDAQ: HSDT · FINANCIAL SERVICES · ASSET MANAGEMENT
$1.65
-2.37% today
Updated 2026-07-29
Market cap
$95.17M
P/E ratio
0.00
P/S ratio
9.92x
EPS (TTM)
$379.14
Dividend yield
—
52W range
$1 – $26
Volume
0.3M
WallStSmart proprietary scores
34
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A7.8
Quality
B+2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
58.6
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$3.50
+112.12%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 58.58 — safe zone
+ Revenue growth 7,290.00% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-4.83M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $787000.00 | $644000.00 | $520000.00 | $6.02M | $9.59M |
| Net income | $-14.07M | $-8.85M | $-11.74M | $-40.89M | $-99.80M |
| EPS | — | — | — | — | $379.14 |
| Free cash flow | $-14.33M | $-10.45M | $-11.05M | $-61.29M | $-4.83M |
| Profit margin | -1,788.06% | -1,374.22% | -2,258.08% | -679.57% | — |
Peer comparison
Smart narrative
Helius Medical Technologies Inc Class A trades at $1.65. Our Smart Value Score of 34/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 58.58, it sits in the safe zone. TTM revenue stands at $9.59M.
Frequently asked questions
What is Helius Medical Technologies Inc Class A's stock price?
Helius Medical Technologies Inc Class A (HSDT) trades at $1.65, on a P/S of 9.9x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Helius Medical Technologies Inc Class A overvalued?
Helius Medical Technologies Inc Class A carries a Smart Value Score of 34/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Helius Medical Technologies Inc Class A (HSDT)?
The 12-month analyst consensus target is $3.50, about 112.1% above the current $1.65. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Helius Medical Technologies Inc Class A's revenue?
Helius Medical Technologies Inc Class A's trailing twelve-month revenue is $9.59M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Helius Medical Technologies Inc Class A's Altman Z-Score is 58.58, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorFINANCIAL SERVICES
IndustryASSET MANAGEMENT
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio9.92x
ROE-137.40%
Beta1.03
50D MA$1.78
200D MA$3.26
Shares out0.06B
Float0.04B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—